Rheumatology Clinical Trials

All the rheumatology clinical trials in Phase III have relied on radiographs to determine the imaging endpoints. The use of MRI has also become an important imaging modality for the assessment of rheumatoid arthritis patients, particularly in the Phase II setting. Only BioClinica has the track record to handle international, multi-center studies of any size that involve radiographs. We understand the critical level of detail that is required to ensure your rheumatology clinical trial’s success. To maximize the radiologist's reading potential, BioClinica cuts and crops all films digitally. Then, we employ Bio-READ™ to ensure the most accurate and precise read.

We offer a variety of rheumatology imaging services for your clinical trials, including:

• Medical Imaging Consulting Services
• Site Standardization and Technical Support
• Image Management Services for X-ray
• Image Management Services for MRI
• Eligibility Assessment Services
• Independent Blinded Reads
• BioREAD
• BioTRACK™
• BioPACS™

Schedule a live demo to learn more about how BioClinica’s rheumatology imaging services can benefit your clinical trials!